 OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 GLOBE NEWSWIRE -- Oxford Immunotec Global PLC Nasdaq: OXFD the Company, a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. The kit, for research use only, has been updated using the Companys growing expertise of the T cell response to SARS-CoV-2 infection. 